New Product
DurA Cycle A50
Driving innovation and performance while
reducing cost of goods.
DurA Cycle A50
Driving innovation and performance while
reducing cost of goods.
As a global leader in resin technology, we develop and manufacture small beads that are used in the most regulated industries in the world to separate, remove or recover very specific elements and compounds.
Learn MoreWith 40 years of manufacturing expertise and 30 years of regulatory experience, we supply leading separation, purification and extraction technologies to support chromatography applications within the Pharma and Medical space.
Learn moreWe are a world leader in resin-based separation, purification and extraction technology, that provides sustainable solutions for our environment, businesses and healthcare.
Learn MorePraesto Jetted A50 to be used in monoclonal antibody treatment.
Purolite Ltd., Cardiff, South Wales - Purolite Ltd., a leading manufacturer of resin-based separation, purification and extraction technologies, today announces that Praesto® Jetted A50, an agarose-based Protein A chromatography resin, has been incorporated into the commercial manufacturing process of an FDA-approved monoclonal antibody treatment by one of the world’s leading contract manufacturing organizations.
Praesto resins are an integral technology used by biopharmaceutical developers for the purification of modern medicines for the treatment of cancer, rheumatoid arthritis, dementia and diabetes. Praesto Jetted A50, launched in April 2018, is Purolite’s ‘best-in-class’ Protein A chromatography resin, utilizing a patented, ‘Jetting’ manufacturing technology for uniform resin beads, a highly desirable characteristic for chromatographic applications.